WO2005030960A1 - ステイプル型オリゴヌクレオチドおよびそれからなる医薬 - Google Patents
ステイプル型オリゴヌクレオチドおよびそれからなる医薬 Download PDFInfo
- Publication number
- WO2005030960A1 WO2005030960A1 PCT/JP2004/014694 JP2004014694W WO2005030960A1 WO 2005030960 A1 WO2005030960 A1 WO 2005030960A1 JP 2004014694 W JP2004014694 W JP 2004014694W WO 2005030960 A1 WO2005030960 A1 WO 2005030960A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stipple
- oligonucleotide
- type oligonucleotide
- type
- bases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
- C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002538215A CA2538215A1 (en) | 2003-09-30 | 2004-09-29 | Staple oligonucleotides and medicaments comprising the same |
JP2005514320A JPWO2005030960A1 (ja) | 2003-09-30 | 2004-09-29 | ステイプル型オリゴヌクレオチドおよびそれからなる医薬 |
AU2004276684A AU2004276684A1 (en) | 2003-09-30 | 2004-09-29 | Staple type oligonucleotide and drug comprising the same |
EP04788459A EP1669450B1 (en) | 2003-09-30 | 2004-09-29 | Staple type oligonucleotide and drug comprising the same |
AT04788459T ATE532865T1 (de) | 2003-09-30 | 2004-09-29 | Klammerartiges oligonukleotid und dieses enthaltender arzneistoff |
CN2004800285477A CN1860228B (zh) | 2003-09-30 | 2004-09-29 | 订书钉型寡核苷酸及包含该订书钉型寡核苷酸的药物 |
US10/568,226 US7595301B2 (en) | 2003-09-30 | 2004-09-29 | Staple type oligonucleotide and drug comprising the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-341419 | 2003-09-30 | ||
JP2003341419 | 2003-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005030960A1 true WO2005030960A1 (ja) | 2005-04-07 |
Family
ID=34386222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/014694 WO2005030960A1 (ja) | 2003-09-30 | 2004-09-29 | ステイプル型オリゴヌクレオチドおよびそれからなる医薬 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7595301B2 (ja) |
EP (1) | EP1669450B1 (ja) |
JP (1) | JPWO2005030960A1 (ja) |
CN (1) | CN1860228B (ja) |
AT (1) | ATE532865T1 (ja) |
AU (1) | AU2004276684A1 (ja) |
CA (1) | CA2538215A1 (ja) |
WO (1) | WO2005030960A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007523658A (ja) * | 2004-02-25 | 2007-08-23 | アラーナ エルティーディー. | アレルギー性疾患を治療するための物質および方法 |
JP2010090103A (ja) * | 2008-02-13 | 2010-04-22 | Gene Design Inc | 新規オリゴヌクレオチド誘導体及びそれから成るNF−κBデコイ |
JP2012130342A (ja) * | 2010-07-08 | 2012-07-12 | Bonac Corp | 遺伝子発現制御のための一本鎖核酸分子 |
WO2013103146A1 (ja) * | 2012-01-07 | 2013-07-11 | 株式会社ボナック | アミノ酸骨格を有する一本鎖核酸分子 |
US10238752B2 (en) | 2012-05-26 | 2019-03-26 | Bonac Corporation | Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
US10612020B2 (en) | 2013-12-26 | 2020-04-07 | Tokyo Medical University | Artificial mimic miRNA for controlling gene expression, and use of same |
US10934542B2 (en) | 2013-12-27 | 2021-03-02 | Bonac Corporation | Artificial match-type miRNA for controlling gene expression and use therefor |
US11027023B2 (en) | 2014-12-27 | 2021-06-08 | Bonac Corporation | Natural type miRNA for controlling gene expression, and use of same |
US11142769B2 (en) | 2015-03-27 | 2021-10-12 | Bonac Corporation | Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007033475A1 (en) * | 2005-09-20 | 2007-03-29 | London Health Sciences Centre Research Inc. | THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
GB2459922A (en) * | 2008-05-13 | 2009-11-18 | Univ Dundee | Treatment for keratinizing dermatological disorders by reduction in keratin expression |
WO2010111891A1 (zh) * | 2009-04-03 | 2010-10-07 | 北京大学 | 修饰的寡聚核酸分子及其制备方法和应用 |
DK2558578T3 (en) | 2010-04-13 | 2016-01-25 | Life Technologies Corp | CONFIGURATIONS AND METHODS FOR INHIBITION OF nucleic acid function |
US8785121B2 (en) | 2010-07-08 | 2014-07-22 | Bonac Corporation | Single-stranded nucleic acid molecule for controlling gene expression |
US8691782B2 (en) | 2010-08-03 | 2014-04-08 | Bonac Corporation | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
KR101894701B1 (ko) * | 2010-08-03 | 2018-09-04 | 가부시키가이샤 보낙 | 함질소 지환식 골격을 갖는 일본쇄 핵산 분자 |
WO2014170441A1 (en) * | 2013-04-19 | 2014-10-23 | Dna Therapeutics | Inhibition of dna damage repair by artificial activation of parp with oligonucleotide molecules |
CN113004362B (zh) * | 2021-02-26 | 2023-08-15 | 南方科技大学 | 一种订书钉核酸、dna纳米机器人及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012633A1 (en) * | 1992-11-24 | 1994-06-09 | Stiefel Laboratories, Inc. | Stable oligonucleotides |
WO1994023026A1 (fr) * | 1993-03-26 | 1994-10-13 | Genset | Oligonuclotides agrafes et semi-agrafes, procede de preparation et applications |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2675803B1 (fr) * | 1991-04-25 | 1996-09-06 | Genset Sa | Oligonucleotides fermes, antisens et sens et leurs applications. |
KR20000065690A (ko) * | 1999-04-08 | 2000-11-15 | 박종구 | 반응 특이성 및 안정성을 개선시킨 안티센스 올리고 뉴클레오타이드, 안티센스 dna 및 그 제조방법 |
-
2004
- 2004-09-29 CN CN2004800285477A patent/CN1860228B/zh active Active
- 2004-09-29 WO PCT/JP2004/014694 patent/WO2005030960A1/ja active Application Filing
- 2004-09-29 AT AT04788459T patent/ATE532865T1/de active
- 2004-09-29 AU AU2004276684A patent/AU2004276684A1/en not_active Abandoned
- 2004-09-29 US US10/568,226 patent/US7595301B2/en active Active
- 2004-09-29 JP JP2005514320A patent/JPWO2005030960A1/ja active Pending
- 2004-09-29 CA CA002538215A patent/CA2538215A1/en not_active Abandoned
- 2004-09-29 EP EP04788459A patent/EP1669450B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012633A1 (en) * | 1992-11-24 | 1994-06-09 | Stiefel Laboratories, Inc. | Stable oligonucleotides |
WO1994023026A1 (fr) * | 1993-03-26 | 1994-10-13 | Genset | Oligonuclotides agrafes et semi-agrafes, procede de preparation et applications |
Non-Patent Citations (2)
Title |
---|
NOVINA, C.D. ET AL.: "siRNA-directed inhibition of HIV-1 infection", NAT. MED., vol. 8, no. 7, 2002, pages 681 - 686, XP002955298 * |
SHIBUYA, T. ET AL.: "A double-strand decoy DNA oligomer for NF-kappaB inhibits TNF alpha-induced ICAM-1 expression in sinusoidal endothelial cells", BIOCHEM. BIOPHYS. RES. COMMUN., vol. 298, 2002, pages 10 - 16, XP002904529 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007523658A (ja) * | 2004-02-25 | 2007-08-23 | アラーナ エルティーディー. | アレルギー性疾患を治療するための物質および方法 |
JP2010090103A (ja) * | 2008-02-13 | 2010-04-22 | Gene Design Inc | 新規オリゴヌクレオチド誘導体及びそれから成るNF−κBデコイ |
JP2012130342A (ja) * | 2010-07-08 | 2012-07-12 | Bonac Corp | 遺伝子発現制御のための一本鎖核酸分子 |
JP2015231381A (ja) * | 2010-07-08 | 2015-12-24 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
WO2013103146A1 (ja) * | 2012-01-07 | 2013-07-11 | 株式会社ボナック | アミノ酸骨格を有する一本鎖核酸分子 |
JPWO2013103146A1 (ja) * | 2012-01-07 | 2015-05-11 | 株式会社ボナック | アミノ酸骨格を有する一本鎖核酸分子 |
US9528111B2 (en) | 2012-01-07 | 2016-12-27 | Bonac Corporation | Single-stranded nucleic acid molecule having amino acid backbone |
US10238752B2 (en) | 2012-05-26 | 2019-03-26 | Bonac Corporation | Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
US10612020B2 (en) | 2013-12-26 | 2020-04-07 | Tokyo Medical University | Artificial mimic miRNA for controlling gene expression, and use of same |
US10934542B2 (en) | 2013-12-27 | 2021-03-02 | Bonac Corporation | Artificial match-type miRNA for controlling gene expression and use therefor |
US11027023B2 (en) | 2014-12-27 | 2021-06-08 | Bonac Corporation | Natural type miRNA for controlling gene expression, and use of same |
US11142769B2 (en) | 2015-03-27 | 2021-10-12 | Bonac Corporation | Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability |
Also Published As
Publication number | Publication date |
---|---|
EP1669450B1 (en) | 2011-11-09 |
AU2004276684A1 (en) | 2005-04-07 |
CN1860228A (zh) | 2006-11-08 |
JPWO2005030960A1 (ja) | 2006-12-07 |
EP1669450A4 (en) | 2009-06-03 |
US20060276421A1 (en) | 2006-12-07 |
US7595301B2 (en) | 2009-09-29 |
CA2538215A1 (en) | 2005-04-07 |
EP1669450A1 (en) | 2006-06-14 |
CN1860228B (zh) | 2010-04-28 |
ATE532865T1 (de) | 2011-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005030960A1 (ja) | ステイプル型オリゴヌクレオチドおよびそれからなる医薬 | |
RU2656154C2 (ru) | СВЯЗАННАЯ С РЕСПИРАТОРНЫМ ЗАБОЛЕВАНИЕМ ГЕН-СПЕЦИФИЧЕСКАЯ миРНК, ДВУСПИРАЛЬНАЯ КОНСТРУКЦИЯ ОЛИГО-РНК, СОДЕРЖАЩАЯ миРНК, И СОДЕРЖАЩАЯ ЕЕ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ИЛИ ЛЕЧЕНИЯ РЕСПИРАТОРНОГО ЗАБОЛЕВАНИЯ | |
JP7049262B2 (ja) | 結合組織成長因子を標的とするrna複合体を用いた特発性肺胞線維症の治療 | |
JP5291129B2 (ja) | 細胞および/または組織および/または疾患フェーズ特異的な薬剤の製造方法 | |
US20160201063A1 (en) | Epigenetic regulators of frataxin | |
JP6944942B2 (ja) | IL4Rα、TRPA1、またはF2RL1を標的とするRNA複合体を用いたアトピー性皮膚炎および喘息の治療 | |
AU2002255285A1 (en) | Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription | |
JP6993230B2 (ja) | キメラデコイ | |
WO2007058323A1 (ja) | 核酸ホモポリマー結合機能性核酸医薬品の製造法 | |
US9233119B2 (en) | Use of HGMA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells | |
JP4510451B2 (ja) | Stat−1依存的遺伝子の発現の調節 | |
WO2007072909A1 (ja) | 新規オリゴヌクレオチド及びそれから成るNF-κBデコイ | |
CN117106781B (zh) | 修饰的核酸及其产品和应用 | |
JP4035348B2 (ja) | 大環状標的選択的アンチセンス核酸化合物 | |
JP2011050381A (ja) | 新規オリゴヌクレオチド誘導体及びそれから成るNF−κBデコイ | |
CN117925623A (zh) | 用于hao1基因编辑和治疗ph1的组合物 | |
JPWO2019107532A1 (ja) | キマーゼに対するアプタマー及びその使用 | |
JPWO2007058323A1 (ja) | 核酸ホモポリマー結合機能性核酸医薬品の製造法 | |
JP2010130900A (ja) | 新規環状ステイプル型オリゴヌクレオチド及びそれから成るNF−κBデコイ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480028547.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006276421 Country of ref document: US Ref document number: 10568226 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005514320 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004276684 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2538215 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004788459 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004276684 Country of ref document: AU Date of ref document: 20040929 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004276684 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004788459 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10568226 Country of ref document: US |